174 related articles for article (PubMed ID: 19184022)
1. [Prognostic and predictive factors of invasive breast cancer: update 2009].
Decker T; Hungermann D; Böcker W
Pathologe; 2009 Feb; 30(1):49-55. PubMed ID: 19184022
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer.
Kondov B; Kondov G; Spirovski Z; Milenkovikj Z; Colanceski R; Petrusevska G; Pesevska M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar; 38(1):81-90. PubMed ID: 28593885
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
Hayashi N; Takahashi Y; Matsuda N; Tsunoda H; Yoshida A; Suzuki K; Nakamura S; Yamauchi H
Clin Breast Cancer; 2018 Apr; 18(2):e219-e229. PubMed ID: 29138067
[TBL] [Abstract][Full Text] [Related]
4. Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India.
Chakraborty A; Bose CK; Basak J; Sen AN; Mishra R; Mukhopadhyay A
Indian J Med Res; 2016 May; 143(Supplement):S45-S51. PubMed ID: 27748277
[TBL] [Abstract][Full Text] [Related]
5. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
6. Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer.
Chung MJ; Lee JH; Kim SH; Suh YJ; Choi HJ
Medicine (Baltimore); 2016 May; 95(20):e3689. PubMed ID: 27196477
[TBL] [Abstract][Full Text] [Related]
7. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse.
Harbeck N; Thomssen C; Berger U; Ulm K; Kates RE; Höfler H; Jänicke F; Graeff H; Schmitt M
Breast Cancer Res Treat; 1999 Mar; 54(2):147-57. PubMed ID: 10424405
[TBL] [Abstract][Full Text] [Related]
8. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
[TBL] [Abstract][Full Text] [Related]
10. Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer.
Partin JF; Mamounas EP
Ann Surg Oncol; 2011 Nov; 18(12):3399-406. PubMed ID: 21537874
[TBL] [Abstract][Full Text] [Related]
11. c-erbB-2 status is an independent predictor of survival after first recurrence.
Horiguchi J; Iino Y; Takei H; Maemura M; Takeyoshi I; Yokoe T; Ohwada S; Oyama T; Nakajima T; Morishita Y
Int J Oncol; 1998 Jan; 12(1):123-8. PubMed ID: 9454895
[TBL] [Abstract][Full Text] [Related]
12. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
13. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
14. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
[TBL] [Abstract][Full Text] [Related]
15. Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer.
Zemzoum I; Kates RE; Ross JS; Dettmar P; Dutta M; Henrichs C; Yurdseven S; Höfler H; Kiechle M; Schmitt M; Harbeck N
J Clin Oncol; 2003 Mar; 21(6):1022-8. PubMed ID: 12637466
[TBL] [Abstract][Full Text] [Related]
16. [Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer].
Kaufmann M; Klinga K; Kühn W; Abel U
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():104-8. PubMed ID: 2703135
[TBL] [Abstract][Full Text] [Related]
17. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
Witzel ID; Milde-Langosch K; Wirtz RM; Roth C; Ihnen M; Mahner S; Zu Eulenburg C; Jänicke F; Müller V
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1709-18. PubMed ID: 20204407
[TBL] [Abstract][Full Text] [Related]
18. [Modern pathologic diagnostics in breast cancer].
Szoke J; Udvarhelyi N
Orv Hetil; 2012 Jan; 153(1):22-30. PubMed ID: 22204831
[TBL] [Abstract][Full Text] [Related]
19. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors. Stage and receptor status in breast cancer.
Donegan WL
Cancer; 1992 Sep; 70(6 Suppl):1755-64. PubMed ID: 1516031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]